Haemophilus influenzae: A significant pathogen in acute otitis media

Pediatric Infectious Disease Journal

Volumn 23, Issue 12, 2004, Pages 1142-1153

  Leibovitz, Eugene ^a   Jacobs, Michael R ^b,c,d   Dagan, Ron ^a,e  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e Department of Pediatric Infectious Disease ^*  (Israel)

Author keywords

Acute otitis; Antibiotic resistance; Antimicrobials; Haemophilus influenzae; Media

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE; CEFACLOR; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CLARITHROMYCIN; COTRIMOXAZOLE; GATIFLOXACIN; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; EARDRUM; ENDOLYMPH; ENZYME SYNTHESIS; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNIZATION; INCIDENCE; MASTOIDITIS; MIDDLE EAR; OTITIS MEDIA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; UNITED STATES; VACCINATION; ACUTE DISEASE; DRUG EFFECT; IMMUNOLOGY; MICROBIOLOGICAL EXAMINATION; PATHOGENICITY;

ACUTE DISEASE; HAEMOPHILUS INFLUENZAE; HUMANS; MENINGOCOCCAL VACCINES; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; VACCINATION;

EID: 16644392313     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000148233.57296.90     Document Type: Review

References (125)

1. Agency for Healthcare Research and Quality. Management of Acute Otitis Media. Rockville, MD: U.S. Department of Health and Human Services; 2001.
2. Freid VM, Makuc DM, Rooks RN. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat. 1998;13:1-23.
3. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287:3096-3102.
4. Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992;120:81-84.
5. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992;11(suppl):S7-S11.
6. Pichichero ME, Pichichero CL. Persistent acute otitis media: I, causative pathogens. Pediatr Infect Dis J. 1995;14:178-183.
7. del Castillo F, Garcia-Perea A, Baquero-Artigao F. Bacteriology of acute otitis media in Spain: a prospective study based on tympanocentesis. Pediatr Infect Dis J. 1996; 15: 541-543.
8. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589-595.
9. Harrison CJ, Marks MI, Welch DF. Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis. 1985;4:641-646.
10. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19:95-104.
11. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20:829-837.
12. Gehanno P, Panajotopoulos A, Barry B, et al. Microbiology of otitis media in the Paris, France area from 1987 to 1997. Pediatr Infect Dis J. 2001; 20:570-573.
13. Rosenblut A, Santolaya ME, Gonzalez P, et al. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J. 2001;20:501-507.
14. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
15. Johnson CE, Carlin SA, Super DM, et al. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr. 1991;19: 117-122.
16. Fujita K, Iseki K, Yoshioka H, Sasaki T, Ando T, Nakamura M. Bacteriology of acute otitis media in Japanese children. Am J Dis Child. 1983;137:152-154.
17. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20:654-662.
18. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study. Pediatr Infect Dis J. 2003;22:943-949.
19. Huebner RE, Wasas AD, Hockman M, Klugman KP. Bacterial aetiology of non-resolving otitis media in South African children. J Laryngol Otol. 2003;117:169-172.
20. Leibovitz E, Raiz S, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J. 1998;17:463-469.
21. Nielsen JC. Studies of the Aetiology of Acute Otitis Media. Copenhagen, Denmark: Munksgaard; 1945.
22. Lahikainen EA. Clinico-bacteriologic studies on acute otitis media aspiration of the tympanum as a diagnostic and therapeutic method. Acta Otolaryngol Suppl. 1953;43:7-82.
23. Mortimer EA Jr, Watterson RL Jr. Bacteriologic investigation of otitis media in infancy. Pediatrics. 1956;17:359-367.
24. Howie VM, Ploussard JH. Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolatetriple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr (Phila). 1972;11: 205-214.
25. Howie VM, Dillard R, Lawrence B. In vivo sensitivity test in otitis media: efficacy of antibiotics. Pediatrics. 1985;75:8-13.
26. Pichichero ME. Recurrent and persistent otitis media. Pediatr Infect Dis J. 2000;19:911-916.
27. Gehanno P, Nguyen L, Barry B, et al. Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media. Antimicrob Agents Chemother. 1999;43:16-20.
28. Marchant CD, Dagan R. Bacteriologic efficacy of antimicrobial agents. In: Rosenfeld RM, Bluestone CD, eds. Evidence-Based Otitis Media. 2nd ed. Hamilton, Canada: BC Decker, Inc, 2003;256-267.
29. Howie VM. Eradication of bacterial pathogens from middle ear infections. Clin Infect Dis. 1992;14(suppl 2):209-211.
30. Leibovitz E, Lang T, Piglansky L, Raiz S, Leiberman A, Dagan R. Bacteriology of acute otitis media in Southern Israel, 1995-2001: relationship to previous antibiotic therapy and disease history. Paper presented at: Third World Congress of Pediatric Infectious Diseases (WSPID); November 19-23, 2002; Santiago, Chile.
31. Brook I, Gober AE. Microbiologic characteristics of persistent otitis media. Arch Otolaryngol Head Neck Surg. 1998;124:1350-1352.
32. Brook I, Gober AE. Reliability of the microbiology of spontaneously draining acute otitis media in children. Pediatr Infect Dis J. 2000;19: 571-573.
33. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
34. Schwartz R, Rodriguez W, Khan W, Ross S. Increasing incidence of ampicillin-resistant Haemophilus influenzae: a cause of otitis media. JAMA. 1978;239:320-332.
35. Schwartz RH. Bacteriology of otitis media: a review. Otolaryngol Head Neck Surg. 1981;89:444-450.
36. Karma P, Luotonen J, Pukander J, Sipila M, Herva E, Gronroos P. Haemophilus influenzae in acute otitis media. Acta Otolaryngol. 1983; 95:105-110.
37. Giebink GS. Microbiology of otitis media. Pediatr Infect Dis J. 1989;8(suppl):S18-S20.
38. Dagan R, Leibovitz E, Leiberman A, Yagupsky P. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J. 2000;19(suppl):S57-S65.
39. Hoberman A, Marchant CD, Kaplan SL, Feldman S. Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila). 2002;41:373-390.
40. Brook I. Otitis media in children: a prospective study of aerobic and anaerobic bacteriology. Laryngoscope. 1979;89:992-997.
41. Hasegawa K, Yamamoto K, Chiba N, et al. Diversity of ampicillin- resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 2003;9:39-46.
42. Bjuggren G, Tunevall G. Otitis in childhood: a clinical and serobacteriological study with special reference to the significance of Haemophilus influenzae in relapses. Acta Otolaryngol. 1952;42:311-328.
43. Howie VM, Ploussard JH. The "in vivo sensitivity test": bacteriology of middle ear exudate, during antimicrobial therapy in otitis media. Pediatrics. 1969;44:940-944.
44. Barenkamp SJ, Shurin PA, Marchant CD, et al. Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain? J Pediatr. 1984;105: 533-537.
45. Leibovitz E, Greenberg D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J. 2003;22:209-216.
46. Schwartz RH, Rodriguez WJ, Khan WN. Persistent purulent otitis media. Clin Pediatr (Phila). 1981;20:445-447.
47. Piglansky L, Leibovitz E, Raiz S, et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J. 2003;22:405-413.
48. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis. 1997;176:1253-1259.
49. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. Pediatr Infect Dis J. 1998;17:1126-1131.
50. Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000;19:1040-1045.
51. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother. 2000;44: 43-50.
52. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J. 1993;12:973-975.
53. Rodriguez WJ, Schwartz RH. Streptococcus pneumonias causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis. Pediatr Infect Dis J. 1999;18:942-944.
54. Palmu AA, Herva E, Savolainen H, Karma P, Makela PH, Kilpi TM. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis. 2004;38:234-242.
55. Heikkinen T, Ghaffar F, Okorodudu AO, Chonmaitree T. Serum interleukin-6 in bacterial and nonbacterial acute otitis media. Pediatrics. 1998;102:296-299.
56. Broides A, Leibovitz E, Dagan R, et al. Cytology of middle ear fluid during acute otitis media. Pediatr Infect Dis J. 2002;21:57-61.
57. Barzilai A, Dekel B, Dagan R, Passwell JH, Leibovitz E. Cytokine analysis of middle ear effusions during acute otitis media: significant reduction in tumor necrosis factor α concentrations correlates with bacterial eradication. Pediatr Infect Dis J. 1999;18:301-303.
58. Barzilai A, Leibovitz E, Laver JH, et al. Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection. 1999;27:173-176.
59. Leibovitz E, Dagan R, Laver JH, et al. Interleukin-8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication. Arch Dis Child. 2000;82:165-168.
60. Barzilai A, Dekel B, Dagan R, Leibovitz E. Middle ear effusion IL-6 concentration in bacterial and non-bacterial acute otitis media. Acta Paediatr. 2000;89:1068-1071.
61. Polachek A, Greenberg D, Lavi-Givon N, et al. Relation between peripheral white blood cell counts, etiologic agents, and clinical manifestations in acute otitis media. Pediatr Infect Dis. 2004;23:406-413.
62. McCormick DP, Lim-Melia E, Saeed K, Baldwin CD, Chonmaitree T. Otitis media: can clinical findings predict bacterial or viral etiology? Pediatr Infect Dis J. 2000;19:256-258.
63. Leibovitz E, Satran R, Piglansky L, et al. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J. 2003;22:509-515.
64. Satran R, Leibovitz E, Raiz S, Piglansky L, Leiberman A, Dagan R. Clinical score (CS) at presentation and during treatment in acute otitis media (AOM): comparison between S. pneumoniae, H. influenzae, and mixed S. pneumoniae + H. influenzae infection. Paper presented at: 40th Conference of the Infectious Diseases Society of America; October 24-27, 2002; Chicago.
65. Bodor FF. Conjunctivitis-otitis syndrome. Pediatrics. 1982;69:695-698.
66. Bodor FF, Marchant CD, Shurin PA, Barenkamp SJ. Bacterial etiology of conjunctivitis-otitis media syndrome. Pediatrics. 1985;76:26-28.
67. Gigliotti F. Acute conjunctivitis. Pediatr Rev. 1995;16:203-207; quiz 8.
68. Weiss A. Acute conjunctivitis in childhood. Curr Probl Pediatr. 1994;24:4-11.
69. Gigliotti F, Williams WT, Hayden FG, et al. Etiology of acute conjunctivitis in children. J Pediatr. 1981;98:531-536.
70. Block SL, Hedrick J, Tyler R, et al. Increasing bacterial resistance in pediatric acute conjunctivitis, 1997-1998. Antimicrob Agents Chemother. 2000;44:1650-1654.
71. Harrison CJ, Hedrick JA, Block SL, Gilchrist MJ. Relation of the outcome of conjunctivitis and the conjunctivitis-otitis syndrome to identifiable risk factors and oral antimicrobial therapy. Pediatr Infect Dis J. 1987;6:536-540.
72. Schneider ML. Bacteriology of otorrhea from tympanostomy tubes. Arch Otolaryngol Head Neck Surg. 1989;115:1225-1226.
73. Mandel EM, Casselbrant ML, Kurs-Lasky M. Acute otorrhea: bacteriology of a common complication of tympanostomy tubes. Ann Otol Rhinol Laryngol. 1994;103:713-718.
74. Goldblatt EL. Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes. Pediatr Infect Dis J. 2001;20:116-119.
75. Bahadori RS, Schwartz RH, Ziai M. Acute mastoiditis in children: an increase in frequency in Northern Virginia. Pediatr Infect Dis J. 2000;19:212-215.
76. Katz A, Leibovitz E, Greenberg D, et al. Acute mastoiditis in Southern Israel: a twelve year retrospective study, 1990 through 2001. Pediatr Infect Dis J. 2003;22:878-882.
77. Luntz M, Brodsky A, Nusem S, et al. Acute mastoiditis: the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol. 2001;57:1-9.
78. Vassbotn FS, Klausen OG, Lind O, Moller P. Acute mastoiditis in a Norwegian population: a 20 year retrospective study. Int J Pediatr Otorhinolaryngol. 2002;62:237-242.
79. Tarantino V, D'Agostino R, Taborelli G, Melagrana A, Porcu A, Stura M. Acute mastoiditis: a 10 year retrospective study. Int J Pediatr Otorhinolaryngol. 2002;66:143-148.
80. Faden H, Stanievich J, Brodsky L, Bernstein J, Ogra PL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J. 1990;9:623-666.
81. Faden H, Duffy L, Williams A, Krystofik DA, Wolf J. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life. J Infect Dis. 1995;172:132-135.
82. Spinola SM, Peacock J, Denny FW, Smith DL, Cannon JG. Epidemiology of colonization by nontypable Haemophilus influenzae in children: a longitudinal study. J Infect Dis. 1986;154:100-109.
83. Faden H, Waz MJ, Bernstein JM, Brodsky L, Stanievich J, Ogra PL. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 1991;100:612-615.
84. Harabuchi Y, Faden H, Yamanaka N, Duffy L, Wolf J, Krystofik D. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. J Infect Dis. 1994;170:862-866.
85. Murphy TF, Dudas KC, Mylotte JM, Apicella MA. A subtyping system for nontypable Haemophilus influenzae based on outer-membrane proteins. J Infect Dis. 1983;147:838-846.
86. Murphy TF, Bartos LC. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect Immun. 1988;56:2673-2679.
87. Murphy TF. Bacterial otitis media: pathogenetic considerations. Pediatr Infect Dis J. 2000;19(suppl):S9-S15; discussion S16.
88. Yamanaka N, Faden H. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children. J Pediatr. 1993;122:212-218.
89. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001;160:407-413.
90. Jorgensen JH. Update on mechanisms and prevalence of antimicrobial, resistance m Haemophilus influenzae. Clin Infect Dis. 1992;14:1119-1123.
91. Gleckman R, Alvarez S, Joubert DW. Drug therapy reviews: trimethoprim-sulfamethoxazole. Am J Hosp Pharm. 1979;36:893-906.
92. Mlynarczyk G, Mlynarczyk A, Jeljaszewicz J. Epidemiological aspects of antibiotic resistance in respiratory pathogens. Int J Antimicrob Agents. 2001;18:497-502.
93. Jacobs MR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J. 2000;19:S47-S55; discussion S56.
94. Ubukata K, Shibasaki Y, Yamamoto K, et al. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 2001;45:1693-1699.
95. Peric M, Bozdogan B, Jacobs MR, Appelbaum PC. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother. 2003;47:1017-1022.
96. Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U. S.Surveillance Study. Antimicrob Agents Chemother. 1999;43:1901-1908.
97. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52:229-246.
98. Howie VM, Ploussard JH, Sloyer J. Comparison of ampicillin and amoxicillin in the treatment of otitis media in children. J Infect Dis. 1974;129(suppl):S18-S184.
99. Marchant CD, Shurin PA, Johnson CE, et al. Randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. J Pediatr. 1986;109:891-896.
100. Howie VM, Owen MJ. Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media. Pediatr Infect Dis J. 1987;6:989-991.
101. Owen MJ, Anwar R, Nguyen HK, Swank PR, Bannister ER, Howie VM. Efficacy of cefixime in the treatment of acute otitis media in children. Am J Dis Child. 1993;147:81-86.
102. Stutman HR, Arguedas AG. Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media. Clin Infect Dis. 1992;14(suppl 2):S204-S208; discussion S9-S11.
103. Easton J, Noble S, Perry CM. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media. Drugs. 2003;63:311-340.
104. Jacobs MR. Assessing the quality of the Alexander Project. J Chemother. 1999;11(suppl 1):26-34.
105. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 1990;34:2075-2080.
106. Sanchez L, Leranoz S, Puig M, Loren JG, Nikaido H, Vinas M. Molecular basis of antimicrobial resistance in non-typable Haemophilus influenzae. Microbiologia. 1997;13:309-314.
107. Sanchez L, Pan W, Vinas M, Nikaido H. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J Bacteriol. 1997;179:6855-6857.
108. Zhanel GG, Ennis K, Vercaigne L, et al. Critical review of the fluoroquinolones: focus on respiratory infections. Drugs. 2002;62:13-59.
109. Nazir J, Urban C, Mariano N, Burns J, Segal-Maurer S, Rahal JJ. Levofloxacin resistant Haemophilus influenzae in a long term care facility. Paper presented at: 42nd International Conference on Antimicrobial Agents and Chemotherapy; 2000; San Diego, CA.
110. Biedenbach DJ, Jones RN. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2003;46:55-61.
111. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-259.
112. Dagan R, Leibovitz E. Bacterial eradication in the treatment of otitis media. Lancet Infect Dis. 2002;2:593-604.
113. Hoberman A, Dagan R, Rosenblut A, Leibovitz E, Huff A, Wynne B. Extra-strength amoxicillin-clavulanate (A/C-ES) vs azithromycin (AZI) for acute otitis media (AOM) in children. Paper presented at: 43rd International Conference on Antimicrobial Agents and Chemotherapy; September 14-17, 2003; Chicago, IL.
114. Marchant CD, Shurin PA, Turcyzk VA, et al. Randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media. J Pediatr. 1984;105:633-638.
115. Patel JA, Reisner B, Vizirinia N, Owen M, Chonmaitree T, Howie V. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J Pediatr. 1995;126:799-806.
116. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J. 2001;20:260-264.
117. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9.
118. Leibovitz E, Dagan R, Arguedas A, et al. Evaluation of once daily cefdinir 25 mg/kg oral suspension in children with acute otitis media at risk of persistent or recurrent otitis media. Paper presented at: 14th European Congress of Clinical Microbiology and Infectious Diseases; 2004; Prague, Czech Republic.
119. Scaglione F. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Pediatr Infect Dis J. 1997;16(suppl):S56-S59.
120. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17:776-782.
121. Dagan R, McCracken GH Jr. Flaws in design and conduct of clinical trials in acute otitis media. Pediatr Infect Dis J. 2002;21:894-902.
122. Kilpi T, Ahman H, Jokinen J, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis. 2003;37: 1155-1164.
123. Block SL, Hedrick JA, Harrison CJ. Routine use of Prevnar in a pediatric practice profoundly alters the microbiology of acute otitis media. Paper presented at: Pediatric Academic Societies' Annual Meeting; May 3-6, 2003; Seattle, WA.
124. McEllistrem M, Adams J, Mason E, Wald E. Changing epidemiology of pneumococcal acute otitis media in the 7-valent conjugate vaccine era. In: 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL: American Society for Microbiology; 2003. (Abstract G-2047):301.
125. Olson LC, Jackson MA. Only the pneumococcus. Pediatr Infect Dis J. 1999;18:849-850.